Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on March 7, 2007
J Am Soc Nephrol 18: 1140-1149, 2007
© 2007 American Society of Nephrology
doi: 10.1681/ASN.2006101127

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2006101127v1
18/4/1140    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shen, B.
Right arrow Articles by El-Dahr, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shen, B.
Right arrow Articles by El-Dahr, S. S.

Genetics and Development

The Bradykinin B2 Receptor Gene Is a Target of Angiotensin II Type 1 Receptor Signaling

Bing Shen*,{dagger}, Lisa M. Harrison-Bernard{ddagger}, Andrew J. Fuller{dagger}, Vanessa Vanderpool*, Zubaida Saifudeen* and Samir S. El-Dahr*

* Department of Pediatrics, Section of Pediatric Nephrology, {dagger} Department of Physiology, Tulane University Health Sciences Center, and {ddagger} Department of Physiology, Louisiana State University Health Sciences Center, New Orleans, Louisiana

Address correspondence to: Dr. Samir S. El-Dahr, Department of Pediatrics, SL-37, Tulane University Health Sciences Center, 1430 Tulane Avenue, New Orleans, LA 70112. Phone: 504-988-377; Fax: 504-988-1852; E-mail: seldahr{at}tulane.edu

Received for publication October 18, 2006. Accepted for publication January 25, 2007.

Cross-talk between G protein–coupled receptors (GPCR) is known to occur at multiple levels, including receptor heterodimerization and intracellular signaling. This study tested the hypothesis that GPCR cross-talk occurs at the transcriptional level. It was demonstrated that the bradykinin B2 receptor gene (BdkrB2) is a direct transcriptional target of the angiotensin II (AngII) type 1 receptor (AT1R) in collecting duct cells. AngII induced BdkrB2 mRNA expression in mouse inner medullary collecting duct cells, and this effect was abrogated by AT1R blockade; in contrast, AT2R blockade was ineffective. Actinomycin D, an inhibitor of gene transcription, abrogated AngII-stimulated BdkrB2 expression. In addition, AngII produced dosage- and time-dependent increases in B2 receptor protein levels (2.9 ± 0.4 fold; P < 0.05). AngII stimulated phosphorylation of cAMP response element binding protein (CREB) on Ser-133 and assembly of p-CREB on the BdkrB2 promoter in vivo. Moreover, AngII induced hyperacetylation of BdkrB2 promoter–associated H4 histones, a chromatin modification that is associated with gene activation. Mutations of the CRE abrogated AngII-induced activation of the BdkrB2 promoter. AngII-treated inner medullary collecting duct cells exhibited augmented intracellular calcium signaling in response to bradykinin, confirming the functional relevance of AT1-B2 receptor signaling. Finally, studies that were conducted in angiotensin type 1 receptor (Agtr1)-null mice revealed that BdkrB2 mRNA levels were significantly lower in the renal medulla of Agtr1A–/– and Agtr1A/B–/– than in Agtr1+/+ and Agtr1B–/– mice. It is concluded that BdkrB2 is a downstream target of the AT1R-CREB signaling pathway. Transcriptional regulation represents a novel form of cross-talk between GPCR that link the renin-angiotensin and kallikrein-kinin systems.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
S. S. El-Dahr, K. Aboudehen, and Z. Saifudeen
Transcriptional control of terminal nephron differentiation
Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1273 - F1278.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
S. Park and L. M. Harrison-Bernard
Augmented Renal Vascular nNOS and Renin Protein Expression in Angiotensin Type 1 Receptor Null Mice
J. Histochem. Cytochem., April 1, 2008; 56(4): 401 - 414.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Park, B. J. Bivona, and L. M. Harrison-Bernard
Compromised renal microvascular reactivity of angiotensin type 1 double null mice
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F60 - F67.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP